Patents by Inventor Yohei Amano

Yohei Amano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240277612
    Abstract: An aspect of the present invention relates to a preparation containing (a) a fatty acid and (b) a phospholipid, in which the mass ratio [(a)/(b)] of the content of the component (a) to the content of the component (b) is 0.5 to 3.0, the total content of the components (a) and (b) is 60 to 100 mass % based on the total amount of the preparation, the content of lipids other than the components (a) and (b) is 30 mass % or less based on the total mass of the preparation, the content of an organic solvent is 30 mass % or less based on the total mass of the preparation, the light transmittance of a water phase at 660 nm when the preparation has been mixed with water 100 times larger than the preparation in volume is 80% or more, and contact with moisture makes it possible to form an oil gel.
    Type: Application
    Filed: June 10, 2022
    Publication date: August 22, 2024
    Applicant: Kewpie Corporation
    Inventor: Yohei Amano
  • Publication number: 20230310443
    Abstract: The present invention relates to an emulsion including aprepitant, an emulsifier, an oil, polyethylene glycol, and water, without substantial addition of ethanol.
    Type: Application
    Filed: April 15, 2021
    Publication date: October 5, 2023
    Applicants: Kewpie Corporation, FBC (Shanghai) Pharmaceutical Technology Co., Ltd.
    Inventors: Yohei Amano, Kazumi Katagiri
  • Patent number: 11571385
    Abstract: The present invention relates to a self-emulsifiable composition including a monoacyl phospholipid, a diacyl phospholipid, oils and fats, and a polyhydric alcohol, in which the content ratio between the monoacyl phospholipid and the diacyl phospholipid is in the range of monoacyl phospholipid:diacyl phospholipid=1:9 to 9:1 as a mass ratio.
    Type: Grant
    Filed: April 4, 2018
    Date of Patent: February 7, 2023
    Assignee: Kewpie Corporation
    Inventor: Yohei Amano
  • Publication number: 20210145743
    Abstract: The present invention relates to a self-emulsifiable composition including a monoacyl phospholipid, a diacyl phospholipid, oils and fats, and a polyhydric alcohol, in which the content ratio between the monoacyl phospholipid and the diacyl phospholipid is in the range of monoacyl phospholipid:diacyl phospholipid=1:9 to 9:1 as a mass ratio.
    Type: Application
    Filed: April 4, 2018
    Publication date: May 20, 2021
    Applicant: Kewpie Corporation
    Inventor: Yohei Amano
  • Publication number: 20140121407
    Abstract: A compound corresponding to 3-[4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]phenyl]propionic acid in which a part or all of hydrogen atoms in the ethylene group constituting the propionic acid moiety are replaced with deuterium atoms, a salt thereof, or an ester thereof, and a prodrug for releasing Am80 as an active medicament after being absorbed into a living body, which comprises the aforementioned compound, a salt thereof, or an ester thereof as an active ingredient.
    Type: Application
    Filed: July 4, 2012
    Publication date: May 1, 2014
    Applicant: RESEARCH FOUNDATION ITSUU LABORATORY
    Inventors: Hideaki Muratake, Koichi Shudo, Yohei Amano, Takahiro Toda
  • Patent number: 8232300
    Abstract: A compound represented by the following general formula (I): [wherein R1 represents hydrogen atom or a C1-6 alkyl group, A and B represent —(CH2)2—, —(CH2)3—or —(CH2)4—, X represents —N(R2)—CO—(R2 represents hydrogen atom or a C1-6 alkyl group), —CO—N(R3)—(R3 represents hydrogen atom or a C1-6 alkyl group), —C(R4)?C(R5)—(R4 and R5 represent hydrogen atom or a C1-6 alkyl group), or —N(R6)—SO2—(R6 represents hydrogen atom or a C1-6 alkyl group), and Ar represents an aryldiyl group or a heteroaryldiyl group], which has a retinoid action and is useful as an active ingredient of a medicament.
    Type: Grant
    Filed: August 14, 2008
    Date of Patent: July 31, 2012
    Assignee: Research Foundation Itsuu Laboratory
    Inventors: Yohei Amano, Masayuki Noguchi, Koichi Shudo
  • Patent number: 8143260
    Abstract: A compound represented by the following general formula (I): [wherein R1 represents hydrogen atom or a C1-6 alkyl group, A and B represent —(CH2)2—, —(CH2)3— or —(CH2)4—, X represents —N(R2)— (R2 represents hydrogen atom or a C1-6 alkyl group), —CO—, —C(?N—R3)— (R3 represents hydrogen atom or a C1-6 alkyl group), or —C(?C(R4)(R5))— (R4 and R5 independently represent hydrogen atom or a C1-6 alkyl group), and Ar represents an aryldiyl group or a heteroaryldiyl group], which has an action of controlling physiological activities of retinoids and useful as an active ingredient of a medicament.
    Type: Grant
    Filed: August 14, 2008
    Date of Patent: March 27, 2012
    Assignee: Research Foundation Itsuu Laboratory
    Inventors: Yohei Amano, Masayuki Noguchi, Koichi Shudo
  • Publication number: 20110288299
    Abstract: A compound represented by the following general formula (I): [wherein R1 represents hydrogen atom or a C1-6 alkyl group, A and B represent —(CH2)2—, —(CH2)3— or —(CH2)4—, X represents —N(R2)— (R2 represents hydrogen atom or a C1-6 alkyl group), —CO—, —C(?N—R3)— (R3 represents hydrogen atom or a C1-6 alkyl group), or —C(?C(R4)(R5))— (R4 and R5 independently represent hydrogen atom or a C1-6 alkyl group), and Ar represents an aryldiyl group or a heteroaryldiyl group], which has an action of controlling physiological activities of retinoids and useful as an active ingredient of a medicament.
    Type: Application
    Filed: August 14, 2008
    Publication date: November 24, 2011
    Applicant: RESEARCH FOUNDATION ITSUU LABORATORY
    Inventors: Yohei Amano, Masayuki Noguchi, Koichi Shudo
  • Publication number: 20110213157
    Abstract: A compound represented by the following general formula (I): [wherein R1 represents hydrogen atom or a C1-6 alkyl group, A and B represent —(CH2)2—, —(CH2)3— or —(CH2)4—, X represents —N(R2)—CO— (R2 represents hydrogen atom or a C1-6 alkyl group), —CO—N(R3)— (R3 represents hydrogen atom or a C1-6 alkyl group), —C(R4)?C(R5)— (R4 and R5 represent hydrogen atom or a C1-6 alkyl group), or —N(R6)—SO2— (R6 represents hydrogen atom or a C1-6 alkyl group), and Ar represents an aryldiyl group or a heteroaryldiyl group], which has a retinoid action and is useful as an active ingredient of a medicament.
    Type: Application
    Filed: August 14, 2008
    Publication date: September 1, 2011
    Applicant: RESEARCH FOUNDATION ITSUU LABORATORY
    Inventors: Yohei Amano, Masayuki Noguchi, Koichi Shudo